Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
FIRST-IN-MAN USE OF VERICIGUAT IN A HEART TRANSPLANT RECIPIENT WITH LATE GRAFT FAILURE
Anno:
2025
A 41-year-old patient with late graft failure from a cardiac transplant performed 12 years earlier was referred to our unit for heart retransplantation in January 2023. Severe cardiac allograft vasculopathy (ISHLT CAV 3) not amenable to revascularization was diagnosed. Given the patient's history of multiple episodes of worsening heart failure…
Leggi di più
CARDIOGENIC SHOCK OUTCOME: EXPERIENCE OF A SINGLE CENTER INSERTED IN A REGIONAL NETWORK FOR CARDIOGENIC SHOCK
Anno:
2025
Background:Cardiogenic shock (CS) management is challenging due to the heterogeneity of clinical presentations, complex hemodynamic perturbations and several complications.Therefore a multidisciplinary shock team and dedicated intensive cardiac care unit (ICCU) are necessary to treat these patients (pts). Purpose:To assess clinical features and outcome of CS pts treated in a…
Leggi di più
Desperate times call for desperate measures: total artificial heart for a case of refractory heart failure
Anno:
2025
B.D, male, 46 years old, suffering from idiopathic dilated cardiomyopathy (DCM) with advanced biventricular involvement, treated with current guideline-directed medical therapy, bearer of S-ICD, previous percutaneous mitral edge-to-edge repair. He accesses our ER for exacerbation of heart failure secondary to atrial fibrillation (AF). Within a few days, because the…
Leggi di più
The Aeson Carmat total artificial heart as a bridge to transplant: a case report
Anno:
2025
Limited donor hearts availability represents the greatest limitation for heart transplant (HTx) in modern times. Long waitlist timings lead patients to undergo HTx only after significantly declining hemodynamic conditions, burdened by the risks associated with their clinical status at time of transplant. In patients not suitable for left ventricular…
Leggi di più
Therapeutic challenges in advanced heart failure and end stage kidney disease
Anno:
2025
Introduction:  heart failure is associated with high mortality rates, that become higher in patients with frequent hospital admissions. Patients with HF and ESKD can be tricky to treat as they’re not eligible for the newest medical therapies, require a multidisciplinary approach and face a higher mortality risk.  Case report: A…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram